Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer
Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer
Not yet recruiting · NCT07720167 · Registry updated 2026-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 2 | 2026-07-22 | NCT07720167 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medical University of South Carolina | 262 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Medical University of South Carolina Hollings Cancer Center | Charleston | United States | 8 |